Saturna Capital’s Gilead Sciences GILD Stock Holding History

Saturna Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,282	Closed	-$357K	–	165
2016 Q2	$357K	Sell	4,282 -7,902	-65%	-$701K	0.01%	136
2016 Q1	$1.12M	Sell	12,184 -100	-0.8%	-$9.02K	0.04%	113
2015 Q4	$1.24M	Sell	12,284 -5,934	-33%	-$617K	0.04%	117
2015 Q3	$1.79M	Buy	18,218 +362	+2%	+$40.2K	0.06%	103
2015 Q2	$2.08M	Buy	17,856 +6,561	+58%	+$717K	0.06%	104
2015 Q1	$1.11M	Buy	11,295 +4,284	+61%	+$435K	0.03%	129
2014 Q4	$661K	Buy	7,011 +3,811	+119%	+$394K	0.02%	152
2014 Q3	$341K	Hold	3,200	–	–	0.01%	216
2014 Q2	$265K	Hold	3,200	–	–	0.01%	229
2014 Q1	$227K	Hold	3,200	–	–	0.01%	210
2013 Q4	$240K	Hold	3,200	–	–	0.01%	214
2013 Q3	$201K	Hold	3,200	–	–	0.01%	228
2013 Q2	$164K	Buy	+3,200	New	+$167K	﹤0.01%	233

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Saturna Capital's GILD Position: Q3 2016 in Review

Saturna Capital sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 4,282 shares — an estimated $357K sold.

Saturna Capital first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $2.08M in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Saturna Capital reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Saturna Capital sold 4,282 Gilead Sciences shares in Q3 2016, an estimated $357K.
Saturna Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
Saturna Capital's Gilead Sciences position peaked at $2.08M in Q2 2015.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Saturna Capital's 13F filing for Q3 2016, filed 14 Nov 2016.